Clinical Trials on Lung, Hyperlucent

Total 55298 results

National Cancer Institute (NCI)

Completed

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Adenosquamous Lung Carcinoma | Bronchioloalveolar Carcinoma | Large Cell Lung Carcinoma | Squamous Cell Lung Carcinoma

United States
Synta Pharmaceuticals Corp.

Terminated

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC (Galaxy 2)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung Adenocarcinoma

United States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
Stanford University
AstraZeneca

Recruiting

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II

United States
Postgraduate Institute of Medical Education and...

Completed

Comparison of Procedural Yield of Bronchoalveolar Lavage Using Three Different Techniques in Subjects Undergoing Flexible Bronchoscopy (BAL-3T)

Bronchoalveolar Lavaage | Diffuse Lung Disease

India
Aga Khan University
Imperial College London; Wellcome Trust

Completed

Multifaceted Intervention for Protection Against Cotton Dust Exposure Among Textile Workers (MultiTex-RCT)

Occupational Diseases | Occupational Lung Disease

Pakistan
West Park Healthcare Centre

Completed

Powered Assist to Improve Ambulation in Severe Lung Disease (REVIVE)

Lung Disease Chronic

Canada
North Bristol NHS Trust
University of Bristol

Unknown

Feasibility and Validity of Remote Lung Function Assessment

Chronic Lung Disease

United Kingdom
The University of Texas Health Science Center,...

Terminated

Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2

Lung Diseases, Obstructive

United States
Ralph G Zinner
Bristol-Myers Squibb

Recruiting

Induction Chemo-Nivo in Unresectable Stage III NSCLC

Lung Cancer, Nonsmall Cell | Lung Cancer Stage III

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection. (Vortex_US)

Lung Cancer | Lung Non-Small Cell Carcinoma | Lung; Node

Italy
Istituto Clinico Humanitas

Recruiting

Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma (SLN_NSCLC)

Lung Cancer

Italy
Gustave Roussy, Cancer Campus, Grand Paris
Daiichi Sankyo, Inc.

Recruiting

Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer (ICARUS-LUNG01)

Metastatic Lung Cancer

France
University of Virginia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Diffuse Parenchymal Lung Disease

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Race, Ethnicity, and Diffuse Parenchymal Lung Disease

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Diffuse Parenchymal Lung Disease

United States
Memorial Sloan Kettering Cancer Center
National Institute of Nursing Research (NINR); University of Virginia

Completed

Lung Cancer Informational Study (LCIS)

Cancer | Stage IV Lung Cancer | Stage III Lung Cancer | Decision-Making | Enhanced Care | Advance Lung Cancer

United States
Imugene Limited

Active, not recruiting

A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma Lung

United States, Australia
University of California, San Francisco
AstraZeneca

Active, not recruiting

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Stage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Not yet recruiting

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Stage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

Canada
Odense University Hospital

Recruiting

Severe Lung Disease in Childhood

Lung Disease Chronic

Denmark
Hacettepe University

Not yet recruiting

Determination of Posture in Patients With Restrictive and Obstructive Lung Disease

Lung Diseases | Lung Diseases, Obstructive | Postural; Defect

Turkey
H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program

Recruiting

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Lung Diseases | Lung Cancer, Protection Against

United States
MedImmune LLC

Completed

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Chronic Lung Disease

United States
Federal Research Clinical Center of Federal Medical...

Unknown

The Study Of Probe-Based Confocal Laser Endomicroscopy Of Distal Airways In Diagnostics Of Lung Diseases (pCLE)

Inflammatory, Interstitial, Rare Lung Diseases

Russian Federation
Seoul National University Hospital

Unknown

Phenotypic Clinical, and Genetic Characteristics of Patients With Nontuberculosis Mycobacteria (Korean NTM)

Nontuberculosis Mycobacterial Lung Disease

Korea, Republic of
Assiut University

Not yet recruiting

HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients

Interstitial Lung Disease
Ayse Ulgey

Not yet recruiting

The Effect of Two Different Intra-abdominal Pressure Applications on "Mechanical Power" in Laparoscopic Cholecystectomy

Ventilator-induced Lung Injury

Turkey
VA Office of Research and Development

Not yet recruiting

Telerehabilitation Following Lung Cancer

Lung Cancer | Lung Neoplasm

United States
St. Joseph's Healthcare Hamilton

Completed

The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging

Lung Diseases | Lung Neoplasm

Canada
University of Maryland, Baltimore
National Institutes of Health (NIH)

Completed

Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)

Lung Cancer

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Lung Injury, Acute

United Kingdom
Vanderbilt University

Terminated

Effects of Oxygen on Lung Tissue During Anesthesia

Lung Injury, Acute

United States
Chinese PLA General Hospital

Unknown

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis (VOCs)

Lung Disease | Lung Neoplasm

China
Lungpacer Medical Inc.

Completed

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing, a First in Human Trial

Ventilator Induced Lung Injury

Paraguay
Sykehuset Telemark
Oslo University Hospital; University of North Carolina; National Institute of...

Withdrawn

Airway Inflammation Among Workers in the Silicon Carbide Processing Industry

Inflammation | Obstructive Lung Disease

Norway
First Affiliated Hospital of Wenzhou Medical University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Interstitial Lung Diseases

China
Memorial Sloan Kettering Cancer Center
AstraZeneca; Genentech, Inc.

Completed

Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers

Non-small Cell Lung Cancer | EGFR-mutant Lung Cancers

United States
Xuzhou Central Hospital

Completed

Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules

Lung Cancer | Lung; Node

China
Amgen

Not yet recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305)

Small-Cell Lung Cancer | Extensive-Stage Small-Cell Lung Cancer
University of California, Davis
National Cancer Institute (NCI)

Recruiting

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) (OBLITERATE)

Oligoprogressive | Non-small Cell Lung Cancer | Small-cell Lung Cancer

United States
Wake Forest University Health Sciences

Recruiting

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Nonsmall Cell Lung Cancer Stage III | Unresectable Non-Small Cell Lung Carcinoma

United States
Dana-Farber Cancer Institute

Recruiting

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Small Cell Lung Carcinoma | Non Small Cell Lung Cancer

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Recruiting

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (SORT)

Non Small Cell Lung Cancer | Non-small Cell Lung Cancer

United States, Canada
University of Chicago

Recruiting

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Lung Cancer | Small-cell Lung Cancer | Extensive-stage Small-cell Lung Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8

United States, Canada, Guam
University Hospital, Antwerp
Universiteit Antwerpen; Belgian Cancer Registry

Enrolling by invitation

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan (ZORALCS)

Smoking Cessation | Lung Cancer | Lung Cancer, Nonsmall Cell | Lung Cancer, Small Cell

Belgium
Mayo Clinic
Medtronic - MITG

Terminated

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) (MARK 1A)

Lung Neoplasms | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | Metastatic Cancer to the Lung

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

Nonsmall Cell Lung Cancer Stage III | Nonsmall Cell Lung Cancer, Stage II

United States
Bristol-Myers Squibb

Completed

Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer

Lung Cancer | Non-small Cell Lung Cancer NSCLC | Small Cell Lung Cancer SCLC

China
GlaxoSmithKline

Completed

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

Lung Cancer, Non-Small Cell | Non-Small-Cell Lung Cancer

United States, Canada, Poland
Hunan Province Tumor Hospital

Completed

Correlation Research of Thioredoxin Reductase in Lung Cancer (TRCRLC)

Non-small Cell Lung Cancer | Benign Neoplasm of Lung

China

Clinical Trials on Lung, Hyperlucent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations